Prevalence of Venous Thromboembolism in the USA: Now and the Future
S Deitelzweig, J Lin, BH Johnson, KL Schulman
Patterns of Bleeding in Congenital Hemophilia Patients with Inhibitors and Very Frequent Bleeding: Analysis from the Hemophilia and Thrombosis Research Society (HTRS) Registry
Neufeld EJ, Cooper DL
Safety of Higher Doses of Recombinant Factor VIIA (RFVIIA) ≥250 mcg/kg in Patients with Congenital Hemophilia Complicated by Inhibitors (CHWI): The Hemophilia and Thrombosis Research Society (HTRS) Registry Experience (2004-2008)
Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL
The Efficacy and Safety of Recombinant Factor VIIA (RFVIIA) in Adult Patients: The Experience of the Hemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)
Kessler CM, Cooper DL, Carr ME
The Usefulness of Registry Data for Understanding Treatment Practices and Clinical Outcomes in Hemophilia: The Experience of the Hemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)
Kessler CM, Gill JC, Cooper DL
Dosing and Effectiveness of Recombinant FVIIA (RFVIIA) in Surgical and Dental Procedures in Congenital Hemophilia with Inhibitors: The Experience of the Hemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)
Valentino LA,Cooper DL
Hemophilia and Thrombosis Research Society (HTRS) Registry Data to Understand Differences in Recombinant Factor VIIA (RFVIIA) Dosing and Clinical Outcomes for the Treatment of Specific Joint Bleeds in Hemophilia
Valentino LA, Cooper DL
Use of Recombinant Factor VIIA (RFVIIA) in Individuals with Congenital Hemophilia B Complicated by Alloantibody Inhibitors to Factor IX: Analysis of Data Capture from the Hemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)
Pipe SW, Cooper DL